Effect of paclitaxel in gefitinib-resistant non-small cell lung cancer (NSCLC) treatment during the COVID-19 pandemic.

被引：0
|
作者：
Mohiuddin, Md [1 ]
Kasahara, Kazuo [1 ]
机构：
[1] Kanazawa Univ, Dept Resp Med, Kanazawa, Ishikawa, Japan
来源：
CLINICAL CANCER RESEARCH | 2020年 / 27卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P27
引用
收藏
页数：1
相关论文
共 50 条
  • [11] In Vitro and in Vivo Efficacy of NBDHEX on Gefitinib-resistant Human Non-small Cell Lung Cancer
    Sha, Huanhuan
    Dong, Shuchen
    Yu, Chen
    Zou, Renrui
    Zhu, Yue
    Lu, Ya
    Zhang, Junying
    Cao, Haixia
    Chen, Dan
    Wu, Jianzhong
    Feng, Jifeng
    JOURNAL OF CANCER, 2020, 11 (24): : 7216 - 7223
  • [12] Combination Effect between Bortezomib and Tumor Necrosis Factor α on Gefitinib-resistant Non-small Cell Lung Cancer Cell Lines
    Kusumoto, Sojiro
    Sugiyama, Tomohide
    Ando, Koichi
    Hosaka, Takamichi
    Ishida, Hiroo
    Shirai, Takao
    Yamaoka, Toshimitsu
    Okuda, Kentaro
    Hirose, Takashi
    Ohnishi, Tsukasa
    Inoue, Fumiko
    Kanome, Tomoko
    Kadofuku, Tsuyoki
    Saijo, Nagahiro
    Adachii, Mitsuru
    Ohmori, Tohru
    ANTICANCER RESEARCH, 2009, 29 (06) : 2315 - 2322
  • [13] Impact of COVID-19 Pandemic on Non-Small Cell Lung Cancer Care
    Zhai, YiYuan
    Chopra, Pooja
    Kang, David
    Robert, Nicholas J.
    Zhang, Wei
    CURRENT ONCOLOGY, 2023, 30 (01) : 769 - 785
  • [14] Synthesis of Flavokawain B and its Anti-proliferative Activity Against Gefitinib-resistant Non-small Cell Lung Cancer (NSCLC)
    Seo, Young Ho
    Oh, Yong Jin
    BULLETIN OF THE KOREAN CHEMICAL SOCIETY, 2013, 34 (12): : 3782 - 3786
  • [15] Potential roles of tumor microenvironment in gefitinib-resistant non-small cell lung cancer: A narrative review
    Chen, Mu-Tong
    Li, Bai-Zhi
    Zhang, En-Pu
    Zheng, Qing
    MEDICINE, 2023, 102 (40) : E35086
  • [16] Clinical Significance of Erlotinib Monotherapy for Gefitinib-resistant Non-small Cell Lung Cancer with EGFR Mutations
    Koyama, Nobuyuki
    Uchida, Yoshitaka
    ANTICANCER RESEARCH, 2013, 33 (11) : 5083 - 5089
  • [17] Current status of diagnosis and treatment of advanced non-small cell lung cancer in China during the COVID-19 pandemic
    Liu, Ming
    Zhao, Wei
    Li, Shiyue
    Chen, Liangan
    Zhou, Chengzhi
    ANNALS OF PALLIATIVE MEDICINE, 2022, 11 (04) : 1231 - 1240
  • [18] Gefitinib in the treatment of elderly patients with advanced non-small cell lung cancer (NSCLC)
    Bearz, Alessandra
    Fratino, Lucia
    Spazzapan, Simon
    Berretta, Massimiliano
    Giacalone, Annalisa
    Simonelli, Cecilia
    Tirelli, Umberto
    LUNG CANCER, 2007, 55 (01) : 125 - 127
  • [19] The Impact of COVID-19 Pandemic on Surgical Treatment of Resectable Non-Small Cell Lung Cancer in Greece
    Tomos, Ioannis
    Kapetanakis, Emmanouil I.
    Dimakopoulou, Konstantina
    Raptakis, Thomas
    Kampoli, Katerina
    Karakatsani, Anna
    Koumarianou, Anna
    Papiris, Spyros
    Tomos, Periklis
    LIFE-BASEL, 2023, 13 (01):
  • [20] Atractyloside inhibits gefitinib-resistant non-small-cell lung cancer cell proliferation
    Yao, Wanxin
    Liu, Chen
    Zhang, Ningyin
    Zhang, Yanmei
    Qian, Yong
    ONCOLOGY LETTERS, 2024, 28 (04)
12345